BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Talks.cam//talks.cam.ac.uk//
X-WR-CALNAME:Talks.cam
BEGIN:VEVENT
SUMMARY: Antibiotic alternatives for the new millennium  - Professor Stig 
 Bengmark\, Honorary Visiting Professor\, Division of Surgery &amp\; Interv
 entional Science\, University             College London\, UK
DTSTART:20141105T090000Z
DTEND:20141105T170000Z
UID:TALK51868@talks.cam.ac.uk
CONTACT:Dr Astrid Englezou
DESCRIPTION:www.regonline.co.uk/antibiotic2014\n\nThe inexorable rise in t
 he incidence of antibiotic resistance in bacterial pathogens\, coupled wit
 h the disappointingly low rate of emergence of new\,clinically useful anti
 biotics\, has refocused attention on finding alternatives to antibiotic tr
 eatments. This event will discuss the potential utility of phages\, probio
 tics\, antimicrobial peptides\, herbal medicines and immune modulation for
  treating human and animal disease. This event has CPD accreditation.\n\nW
 ho Should Attend \nFrom researchers trying to find alternatives to therapi
 es to pharmacists delivering treatments: any one with an interest in antib
 iotic alternatives would find this event of value.\n\nThis event has an op
 en oral and poster session.  \nAbstract can be submitted on any subject re
 lated to antibiotic alternatives\n\nThe deadline for abstract submissions 
 for oral presentation is August 10th 2014\nAbstracts for poster presentati
 on only can be submitted up to two weeks before the event. You can downloa
 d the instructions for authors at  www.euroscicon.com/ABSTRACTSUBMISSIONS.
 pdf \n\nTalks Include:\n\nNovel Host Therapeutic Targets regulating M.tube
 rculosis infection\nMr Cornelis Korbee\, PhD Student\, Leiden University M
 edical Center\, The Netherlands\n\nPro- & Synbiotics - an alternative to a
 ntibiotics?                                       \nProfessor Stig Bengmar
 k\, Honorary Visiting Professor\, Division of Surgery & Interventional Sci
 ence\, University             College London\, UK\n\nHBD3 regulates matrix
  metalloproteinase production in human myeloid dendritic cells exposed to 
 Porphyromonas gingivalis hemagglutinin B (HagB)\nProfessor Kim A. Brogden\
 , Director\, Dows Institute for Dental Research\,  The University of Iowa\
 , USA \n\nQuorum sensing inhibitors as an alternate to conventional antibi
 otics Dr. Pragasam Viswanathan\, Associate Professor\, VIT University\, In
 dia \n\nSerendipity\, bees\, honey and wounds.\nDr Matthew Dryden\, Royal 
 Hampshire County Hospital\, UK\n\nAntibiotic versus maggot therapy in diab
 etic foot ulcer\nProfessor Chumpon Wilasrusmee\, Department of Surgery\, F
 aculty of Medicine Ramathibodi Hospital\, Mahidol University\, Thailand\nD
 evelopment of bacteriocins for therapy of infections caused by Gram positi
 ve and negative MDR pathogens\nDr Mathew Upton\, School  of Biomedical & H
 ealthcare Sciences\, Plymouth University\, Plymouth\, UK\n\nBacteriophages
  for antistaphylococcal therapies – natural repertoire and limitations o
 f choice\nDr Hab  Algorzata\, Institute of Biochemistry and Biopysics of t
 he Polish Academy of Sciences\, Faculty of Agriculture and Biology\, Warsa
 w University of Life Sciences\, Poland\n\nHost-Defense Peptides to New Ant
 imicrobial Agents\nDr Paul R. Hansen\, University of Copenhagen\, Denmark\
 n\nAnti-microbial cationic peptides as a strategy for innovation in global
  health therapeutics for human infectious diseases\nDr Hussin Rothan\, Res
 earcher\, Faculty of Medicine\, University of Malaya\, Kuala Lumpur \, Mal
 aysia\n\nAntibodies as a limitless source of peptides with innate microbic
 idal and immunomodulatory activity (ultrabodies)\nProfessor Luciano Polone
 lli\, Full University Professor\, University of Parma\, Italy\n\nOctapepti
 ns revisited \nDr Tony Velkov\, Monash Institute of Pharmaceutical Science
 s\, Victoria\, Australia\n\nUsing molecular simulations to understand the 
 dual action of peptides in antimicrobial activity and innate immune modula
 tion\nDr Peter J Bond\, Principal Investigator Bioinformatics Institute\, 
 A*STAR\, Singapore.  Adjunct Assist. Professor\, Dept. Biological Sciences
 \, National University of Singapore\, Singapore\n\nPreclinical development
  of a novel synthetic antimicrobial peptide for lung infections and sepsis
 \nDr Alessandro Pini\, Dept. of Medical Biotechnology\, University of Sien
 a\, SetLance srl Toscana Life Sciences\, Italy\n\nEnhancing Host Resistanc
 e against Lethal Infections\nProfessor Roger M. Loria\, Virginia Commonwea
 lth University Medical Center\, Richmond\, Virginia\, USA\n\nEchinoderms a
 s source of novel antimicrobial peptides to contrast human pathogens\nDr D
 omenico Schillaci\, Lecturer\, University of Palermo\, Palermo\, Italy\n\n
 War against Microbes: are Antibiotics the only Weapons?\nDr. Jayanta Halda
 r\, Jawaharlal Nehru Centre for Advanced Scientific Research\, Bangalore\,
  India\n\nAntibiotics in Modulation of M1 and M2 Macrophage Responses\nDr 
 Charles Mills\, BioMedical Consultants\, USA\n\nProbiotic bacteria against
  multiresistant pathogens\nProfessor Iryna Sorokulova\, Auburn University\
 , Auburn\, AL\, USA\n\nAntibiotic therapy corroborated by selected immunom
 odulating beta blockers                              \nDr. Karin Peuschel\
 , CNP\, Switzerland\n\nThe potential use and delivery of bacteriophages fo
 r the treatment of Staphylococcus aureus wound biofilm infections\nDiana R
 . Alves\, University of Bath\, UK\n\nClinical Application of Probiotics in
  Antibiotic Therapy: the Current and Future Use\nDr Thomas A. Tompkins\, R
 esearch Director\, Lallemand Health Solutions Inc\, Montreal\, Canada\n\n\
 n\n 
LOCATION:Cineworld: The O2\, Peninsula Square\, London\, SE10 0DX
END:VEVENT
END:VCALENDAR